BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SNCA
,
G-protein-coupled receptor binding
,
Pseudomonas infection
,
Liver
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IDH 2
Summary
General Info
Curated Studies
Most Correlated Studies
Isocitrate Dehydrogenase (IDH) Mutations in HCT116 isogenic clones
CD8+ T-cells treated with PMA and ionomycin post treatment with R-2-hydroxyglutarate
Astrocytes with IDH1 R132H expression doxycycline induced and withdrawn
Acute myeloid leukemia (AML) allografts with mutant IDH2-R14Q conditional deletion
Hepatoblasts overexpressing wildtype or mutant IDH1 or IDH2
Explore Curated Studies Results
Literature
Most Relevant Literature
IDH2 mutations in acute myeloid leukemia.
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial ca…
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AM…
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
IDH1/2 Mutations in Sinonasal Undifferentiated Carcinomas : Previously Undescribed IDH2 R172K and R1…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Niraparib In Recurrent IDH 1/2 Gliomas
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG)…
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
Nivolumab for Recurrent or Progressive IDH Mutant Gliomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ